HopeStage
Back to all studies
CompletedNCT01402492

Buprenorphine With Naltrexone for Cocaine Use

About this titleRead the official source — NCT01402492
Medication studyAges 18–65United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
Los Angeles and 10 more locationsSee all locations and recruitment
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateSeptember 2011
Recruitment status
Completed
Enrollment listed in the registry
302
Sponsor
University of California, Los Angeles
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT01402492
Official title
Show the full official title

Cocaine Use Reduction With Buprenorphine (CURB)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Los Angeles · San Francisco · Denver

8 more locations
  • Washington D.C.
  • Atlanta
  • New York
  • The Bronx
  • Columbus
  • Portland
  • San Antonio
  • Seattle

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of California, Los Angeles, a university.

Did this study involve medication?

Yes. The study involved medication, including Buprenorphine + Naltrexone and Placebo + Naltrexone.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies